Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
number included
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim is to evaluate the impact of a 3-week lasting residential rehabilitation program for patients with cystic fibrosis on their nutritional status measured as BMI and body composition and pulmonary function.
Cystic fibrosis Patients following a residential rehabilitation program consisting of dietary adaptation, physical therapy for airway drainage and supervised inhalation therapy and physical activity for at least 3 weeks are asked to participate. Weight, height, body composition and pulmonary function will be measured at start and end of the program. Dietary intake during the program is calculated based on a 2 day weighed intake diary and physical activity will be measured with the "SenseWear pro 3" armband.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| rehabilitation | All included patients get an pre-intervention and a post intervention analysis |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Rehabilitation | Other | During the rehabilitation program a multidisciplinary team, consisting of a pneumologist, dietician, psychologist, social worker and several physiotherapists, coach the cystic fibrosis patients. The physiotherapists help with autogenic drainage and aerosol therapy (2-3 times/day) and supervise physical activity (5, 1-hour lasting, training sessions/week: swimming 2, Fitness training 2, 1 session of choice). The dietician calculates basal and theoretical energy needs . A carbohydrate-rich snack before exercise, to improve exercise tolerance and a carbohydrate-protein-rich snack afterwards to improve recuperation is provided. |
| Measure | Description | Time Frame |
|---|---|---|
| body composition change | Dual energy X-ray absorptiometry measured Fat mass index (kg/m*2) | day 0 and day 21 (start and end of the rehabilitation program) |
| body composition change | Dual energy X-ray absorptiometry measured fat free mass (kg/m*2) | day 0 and day 21 (start and end of the rehabilitation program) |
| Body mass index change | calculated based on weight and height (kg/m*2) converted in standard deviations | day 0 and day 21 (start and end of the rehabilitation program) |
| Weight change | Scale weighed weight (kg) converted in standard deviations of normal population of normal populations | day 0 and day 21 (start and end of the rehabilitation program) |
| pulmonary function change | forced expiratory volume in 1 second (% of normal) | day 0 and day 21 (start and end of the rehabilitation program) |
| pulmonary function change | Forced Vital capacity (% of normal) | day 0 and day 21 (start and end of the rehabilitation program) |
| Measure | Description | Time Frame |
|---|---|---|
| Physical activity | "SenseWear pro 3" armband measured physical activity | Week 1 |
| dietary intake | macronutrient intake measured based on 2 days/week weighed nutritional intake |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients With Cystic Fibrosis
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Stephanie Van Biervliet, MD, PhD | Gent university hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Zeepreventorium de Haan | De Haan | 8420 | Belgium |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003550 | Cystic Fibrosis |
| ID | Term |
|---|---|
| D010182 | Pancreatic Diseases |
| D004066 | Digestive System Diseases |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D012046 | Rehabilitation |
| ID | Term |
|---|---|
| D000359 | Aftercare |
| D003266 | Continuity of Patient Care |
| D005791 | Patient Care |
| D013812 | Therapeutics |
Not provided
Not provided
Not provided
Not provided
Not provided
|
| 2 days/week for 3 consecutive weeks |
| D030342 |
| Genetic Diseases, Inborn |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| D007232 | Infant, Newborn, Diseases |
| D006296 |
| Health Services |
| D005159 | Health Care Facilities Workforce and Services |